| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/23/2006 | EP1693376A2 Crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
| 08/23/2006 | EP1693191A1 Composite flexible transpirable device formed from separate layers of textile material joined together by a layer of adhesive polymer |
| 08/23/2006 | EP1693073A2 Wound dressings comprising hydrated hydrogels and enzymes |
| 08/23/2006 | EP1693067A1 Pharmaceutical anti-herpetic composition, method for producing a dosage form based thereon and method for the use thereof |
| 08/23/2006 | EP1693058A1 Prevention and measures for viral infection |
| 08/23/2006 | EP1693057A1 Confectionery products containing caffeine |
| 08/23/2006 | EP1693056A1 Cellulose hard capsule shell with enhanced mechanical film strength containing iota-carrageenan and agar |
| 08/23/2006 | EP1693055A2 Gelatin hard capsule having enhanced film strength |
| 08/23/2006 | EP1693054A2 Lactic acid polymer and process for producing the same |
| 08/23/2006 | EP1693053A2 Steroid solution aerosol products with enhanced chemical stability |
| 08/23/2006 | EP1693052A1 Compositions for delivery of drug combinations |
| 08/23/2006 | EP1693051A1 Composition containing chitosan for sustained drug release |
| 08/23/2006 | EP1692951A1 Topical antifungal composition |
| 08/23/2006 | EP1692948A2 Vitamin powders for beverage applications |
| 08/23/2006 | EP1692444A2 Process for co-spray drying agents with dry silicified mcc |
| 08/23/2006 | EP1692216A1 Form of administration based on crosslinked hydrophilic polymers |
| 08/23/2006 | EP1692087A1 Lutein concentrate |
| 08/23/2006 | EP1691892A2 Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same |
| 08/23/2006 | EP1691870A1 Powder inhaler |
| 08/23/2006 | EP1691844A1 Methods and compositions for treatment of interferon-resistant tumors |
| 08/23/2006 | EP1691839A1 Combined doses |
| 08/23/2006 | EP1691826A1 Excipients in drug delivery vehicles |
| 08/23/2006 | EP1691824A2 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 08/23/2006 | EP1691823A2 Transdermal system for sustained delivery of polypeptides |
| 08/23/2006 | EP1691815A1 Superoxide dismutase mimics for the treatment of optic nerve and retinal damage |
| 08/23/2006 | EP1691808A1 Pharmaceutical composition for oral administration of a pyrazol-3-carboxamide derivative |
| 08/23/2006 | EP1691798A1 Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions |
| 08/23/2006 | EP1691795A2 Pharmaceutical compositions comprising danazol |
| 08/23/2006 | EP1691794A2 Form of administration for controlling primary headaches |
| 08/23/2006 | EP1691793A1 Administration form based on cross-linked hydrophilic polymers |
| 08/23/2006 | EP1691791A2 Capsules of multilayered neutral polymer films associated by hydrogen bonding |
| 08/23/2006 | EP1691790A1 Sustained release torsemide dosage forms |
| 08/23/2006 | EP1691789A2 Carvedilol free base, salts, anhydrous forms or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
| 08/23/2006 | EP1691788A2 Phosphodiesterase v inhibitor formulations |
| 08/23/2006 | EP1691787A1 Method for making pharmaceutical multiparticulates |
| 08/23/2006 | EP1691786A1 Multiparticulate compositions with improved stability |
| 08/23/2006 | EP1691785A1 Excipients in drug delivery vehicles |
| 08/23/2006 | EP1691784A1 Biodegradable triblock copolymers as drugs solubilizing agents and method of use |
| 08/23/2006 | EP1691783A1 Pre-metered dry powder inhaler for moisture-sensitive medicaments |
| 08/23/2006 | EP1691782A1 Medical product containing tiotropium |
| 08/23/2006 | EP1691781A1 Inhalable tiotropium and container therefor |
| 08/23/2006 | EP1691780A2 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification |
| 08/23/2006 | EP1691746A2 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 08/23/2006 | EP1691745A2 Methods and compositions for treating skin wounds |
| 08/23/2006 | EP1691744A2 Methods and reagents for the treatment of inflammatory disorders |
| 08/23/2006 | EP1691743A2 Regulation of cell membrane-mediated effects |
| 08/23/2006 | EP1691718A1 Therapeutic microparticles |
| 08/23/2006 | EP1691715A2 Surfactant-based gel as an injectable, sustained drug delivery vehicle |
| 08/23/2006 | EP1515740B1 Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 08/23/2006 | EP1485084B9 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye |
| 08/23/2006 | EP1453929B1 Methods of making film structures |
| 08/23/2006 | EP1441785A4 Improved method for generating an aerosol |
| 08/23/2006 | EP1432414B1 Nail varnish containing tazarotene and use thereof for treating and/or preventing psoriasis |
| 08/23/2006 | EP1402913B1 Dry powder inhalation system for transpulmonary administration, method of manufacturing a dry powdered preparation, and use of a freeze dried composition |
| 08/23/2006 | EP1401445B1 Crystalline anticholinergic, method for its production, and use thereof in the production of a drug |
| 08/23/2006 | EP1399501B1 Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug |
| 08/23/2006 | EP1385528B1 Disinfecting and solubilizing steroid compositions |
| 08/23/2006 | EP1383375B1 A release pharmaceutical construct for gastric retention |
| 08/23/2006 | EP1339294B1 Nutritional composition for an immune condition |
| 08/23/2006 | EP1315537B1 System for myocardial infarction repair |
| 08/23/2006 | EP1292612B1 Glycopeptide phosphonate derivatives |
| 08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
| 08/23/2006 | EP1237537B1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 08/23/2006 | EP1212058B1 Topical treatment for prevention of ocular infections |
| 08/23/2006 | EP1037673B1 Charged lipids and uses for the same |
| 08/23/2006 | EP1033976B1 Microsphere reservoirs for controlled release application |
| 08/23/2006 | EP0998916B1 Medicinal compositions for application to mucosa |
| 08/23/2006 | EP0914827B1 Ophthalmic drug compositions |
| 08/23/2006 | CN1823091A 功能性淀粉粉末 Functional starch powder |
| 08/23/2006 | CN1822859A Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
| 08/23/2006 | CN1822844A Glycoside-containing liposome |
| 08/23/2006 | CN1822843A Process for preparing particles containing an antiviral |
| 08/23/2006 | CN1822842A Solid pharmaceutical preparation |
| 08/23/2006 | CN1822824A Method of treating degenerative disc disease |
| 08/23/2006 | CN1822823A Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
| 08/23/2006 | CN1822822A Saquinavir mesylate oral dosage form |
| 08/23/2006 | CN1822821A Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form |
| 08/23/2006 | CN1822820A Treatment and prevention of cardiovascular events |
| 08/23/2006 | CN1822819A Oral controlled release forms useful for reducing or preventing nicotine cravings |
| 08/23/2006 | CN1822818A Particles containing an acitve agent in the form of a co-precipitate |
| 08/23/2006 | CN1822817A Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 08/23/2006 | CN1822816A Implantable elastomeric depot compositions and uses thereof |
| 08/23/2006 | CN1822815A Intravaginal drug delivery devices |
| 08/23/2006 | CN1822814A Sustained release dosage forms of anesthetics for pain management |
| 08/23/2006 | CN1821255A Total giamt St.John' swort Herb flavone extract, its preparing method and use |
| 08/23/2006 | CN1821253A Novel water soluble Pt (II) anti-cancer ligand and its preparing method |
| 08/23/2006 | CN1821249A Crystal-free type Idi prone and its preparing method |
| 08/23/2006 | CN1820798A Capsule type digestive tract medicine releasing and sampling device |
| 08/23/2006 | CN1820783A Thyroid hormone medicinal preparation |
| 08/23/2006 | CN1820782A Thyroid hormone medicinal preparation and its preparing method |
| 08/23/2006 | CN1820780A Method for preparing Fuyankang extract |
| 08/23/2006 | CN1820776A Process for preparing micrometer yinlanzha, konjak, sugar, fat reducing and weight reducing oral liquor |
| 08/23/2006 | CN1820775A Process for preparing micrometer yinlanzha, konjak, sugar, fat reaucing and weight reducing granule, capsule and tablet |
| 08/23/2006 | CN1820772A Medicine for treating rheumatic arthritis and its preparing method |
| 08/23/2006 | CN1820770A Chinese medicine composition for treating apoplexy and its preparing method |
| 08/23/2006 | CN1820768A Process for preparing micrometer ginseng, tortoise, pearl and pollen oral liquor for nourishing yin, removing fatigue and supplementing calcium |
| 08/23/2006 | CN1820767A Process for preparing micrometer ginseng, tortoise pearl pollen granules, capsule and tablet for nourishing yin, removing fatigue and supplementing granule calcium |
| 08/23/2006 | CN1820766A Process for preparing micrometer ginseng, pilose antler, pearl and pine pollen oral liquor for strengthening yang, removing fatigue and supplementing calcium |
| 08/23/2006 | CN1820765A Process for preparing micrometer ginseng, pilose antler, pearl and pine pollen calcium supplement granule capsule and tablet for strengthening yang, removing fatigue and supplementing calcium |
| 08/23/2006 | CN1820763A Process for preparing micrometer Huishusanhua lucid ganoderma spore anti-tumour mutation granule, capsule and tablet |